Clinical trial · Interventional
Spectroscopy With Surface Coils and Decoupling
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) naturally present in your body using radio waves. To receive this information from your body, small loops of wire (surface coils), placed near the tissue of interest, may be used to more effectively detect signals that come from the chemicals in your body. The investigators may use a second radio channel simultaneously, which will allow us to obtain greater chemical information (decoupling). The results may also help us to understand how this study can be used to help other patients with your condition.
Conditions
Conditions (19)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adrenal Cortical Cancer | — | UNRESOLVED | — |
| Brain Cancer | Malignant Brain Neoplasm | ALIAS | 0.90 |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| CNS Cancer | Malignant Central Nervous System Neoplasm | ALIAS | 0.90 |
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| HEENT Cancer | — | UNRESOLVED | — |
| Hodgkin's Disease | Hodgkin Lymphoma | ALIAS | 0.90 |
| Kaposi's Sarcoma | Kaposi Sarcoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 1H Spectroscopy at 1.5T and 3T | Device | — | UNRESOLVED |
| Proton-decoupled 31P MRS at 1.5T | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 1
- interventionNames
- Device: Proton-decoupled 31P MRS at 1.5T
- Device: 1H Spectroscopy at 1.5T and 3T
Primary outcomes (1)
- measure
- To obtain high resolution spectra from tumors using surface coils to improve sensitivity.
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- In some of these studies, to enhance our spectral resolution and obtain additional metabolic information, we propose to use decoupling, which will increase both signal quality (the signal to noise ratio) and spectral resolution.
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients must have suspected or documented neoplastic disease, strongly suspected or established by physical examination, history or conventional histologic biochemical or imaging techniques, or have surgical or aspiration biopsy that will be used to establish a diagnosis * Patients with obstructive jaundice, both from malignant and non-malignant disease, will be considered for the study * Patients/volunteers must be clinically stable and not require cardiovascular monitoring * Patients must be 6 years of age or older and be able to cooperate for an approximately 60 minute examination * Volunteers must be 18 years of age or older Exclusion Criteria: * Inability to cooperate for an MR exam * Contraindication to MR: Pacemaker, Aneurysmal clips Any ferrous metallic implants which could be deflected by the magnet, Metal implants in field of view, Pregnant women, OR Age and mental status wherein he/she is unable to cooperate for MR study
References
Publications (0)
Data not yet available